logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
F

Filippo de Marinis

University of Ulsan

79H-index
726Paper Count
4.6WCitation Count
Published Papers 189
Publication Date
logo
Plain language summary of the ALINA study results: alectinib compared with chemotherapy after surgery in people with ALK-positive non-small cell lung cancer
errFuture Science OA
IF2.1
err2025-12-31
err0
PREAI
errWu, Yi-Long; Dziadziuszko, Rafal; Ahn, Jin Seok; Barlesi, Fabrice; Nishio, Makoto; Lee, Dae Ho; Lee, Jong-Seok; Zhong, Wenzhao; Horinouchi, Hidehito; Mao, Weimin; Hochmair, Maximilian; De Marinis, Filippo; Migliorino, Maria Rita; Bondarenko, Igor; Lu, Shun; Wang, Qun; Lohmann, Tania Ochi; Xu, Tingting; Cardona, Andres; Hiles, Laura; Noe, Johannes; Solomon, Benjamin J.
errShare
errSave
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer
errEuropean Journal of Cancer
IF7.1
err2025-10-30
err0
PREAI
errJessica Menis; Laurent Greiller; Pierre Demontrond; Isabelle Monnet; Silvia Novello; Lorenzo Livi; Robin Young; Chantal Decroisette; Nicolas Cloarec; Gilles Robinet; Roland Schott; Jerome Fayette; Giuseppe Luigi Banna; Filippo De Marinis; Raffaele Califano; Boris Duchemann; Andrea Luciani; Ida Colantonio; Beatrice Fournier; Yassin Pretzenbacher; Caroline Caramella; Mario Silva; Thierry Berghmans; Anne-Marie Dingemans; Paolo Bironzo; Jonathan Tugwood; Cong Zhou; Steven Hill; Kieran Bradbury; Karen Morris; Elaine Kilgour; Caroline Dive; Fiona Blackhall; Benjamin Besse
errShare
errSave
Letter Re: TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma
errEuropean Journal of Cancer
IF7.1
err2025-10-04
err0
PREAI
errLuca Bertolaccini; Filippo de Marinis; Lorenzo Spaggiari
errShare
errSave
Actionable Gene Alterations in Resected Non-small cell lung cancer: primary results from the AGA-R study
errClinical Lung Cancer
IF3.3
err2025-10-03
err0
PREAI
errIlaria Attili; Gloria Pellizzari; Luca Bertolaccini; Carla Corvaja; Davide Vacirca; Mariano Lombardi; Gianluca Spitaleri; Pamela Trillo Aliaga; Ester Del Signore; Antonio Passaro; Juliana Guarize; Elena Guerini Rocco; Nicola Fusco; Lorenzo Spaggiari; Filippo de Marinis
errShare
errSave
Optimizing Management of Cutaneous Toxicities from Amivantamab in First-Line Non-Small Cell Lung Cancer: A Clinical Perspective
errcritical reviews in oncology hematology
IF0
err2025-09-06
err0
PREAI
errIlaria Attili; Giulio Tosti; Francesca Pepe; Antonio Passaro; Filippo de Marinis
errShare
errSave
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-09-01
err9
PREAI
errYang, James Chih-Hsin; Lu, Shun; Hayashi, Hidetoshi; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Kim, Yu Jung; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Passaro, Antonio; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong Ignatius; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan Carlos; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet Ali Nahit; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Kim, Sang-We; Gadgeel, Shirish M.; Owen, Scott; Xie, John; Sun, Tao; Mehta, Jaydeep; Venkatasubramanian, Raja; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Roshak, Amy; Man, Julie; Knoblauch, Roland E.; Bauml, Joshua M.; Baig, Mahadi; Shah, Sujay; Sethi, Seema; Cho, Byoung Chul
errShare
errSave
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial
errlancet
IF0
err2025-08-07
err0
PREAI
errFabrice Barlesi; Wenxiu Yao; Michaël Duruisseaux; Ludovic Doucet; Aitor Azkárate Martínez; Vanesa Gregorc; Oscar Juan-Vidal; Shun Lu; Charlotte De Bondt; Filippo de Marinis; Helena Linardou; Young-Chul Kim; Robert Jotte; Enriqueta Felip; Giuseppe Lo Russo; Martin Reck; Mary F Michenzie; Wenjing Yang; Julie N Meade; Beata Korytowsky; Tony S K Mok
errShare
errSave
Digital Versus Manual PD-L1 Scoring in Advanced Non-Small Cell Lung Cancer From the IMpower110 and IMpower150 Trials
errJournal of Thoracic Oncology
IF20.8
err2025-08-05
err0
PREAI
errRoy S. Herbst; Hen Prizant; Daniel Ruderman; Jake Conway; John Shamshoian; Hartmut Koeppen; Wei Zou; Filippo de Marinis; Giuseppe Giaccone; Jacek Jassem; David R. Spigel; Mark A. Socinski; Martin Reck; Luciana Molinero; Marcus Ballinger; David Shames; Michael Griffin; Limin Yu; Nishant Agrawal; Andrew Beck; Ilan Wapinski; Stephanie Hennek; Jennifer Giltnane; Minu K. Srivastava
errShare
errSave
THE ITALIAN MAURIS PHASE IIIB TRIAL OF ATEZOLIZUMAB PLUS CARBOPLATIN AND ETOPOSIDE FOR PATIENTS WITH NEWLY DIAGNOSED EXTENSIVE-STAGE SMALL CELL LUNG CANCER: 3-YEAR END-OF-STUDY RESULTS
errClinical Lung Cancer
IF3.3
err2025-07-09
err0
errOAAI
errFloriana Morgillo; Ester Del Signore; Emilio Bria; Filippo de Marinis; Fortunato Ciardiello; Marina Chiara Garassino; Alessio Stefani; Francesco Verderame; Alessandro Morabito; Andrea Sbrana; Giuseppe Tonini; Marina Gilli; Rossana Berardi; Paola Adriana Taveggia; Alessandra Bearz; Angelo Delmonte; Maria Rita Migliorino; Cesare Gridelli; Giovanni Maria Fadda; Manuela Iero; Andrea Ardizzoni
errShare
errSave
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study
errAnnals of Oncology
IF65.4
err2025-06-02
err0
errOAAI
errF. de Marinis; T.M. Kim; L. Bonanno; S. Cheng; S.-W. Kim; M. Tiseo; Q. Chu; C. Proto; A. Sacher; Y.-H. Luo; S. Novello; D. Hao; C. Baik; L. Bazhenova; J.S. Lee; B.C. Cho; J. Cadranel; T.B. Diep; G. Metro; P. Narayanan; M.-J. Ahn
errShare
errSave
Dealing with KRAS G12C inhibition in non-small cell lung cancer (NSCLC) - biology, clinical results and future directions
errCANCER TREATMENT REVIEWS
IF10.5
err2025-06-01
err0
PREAI
errAttili, Ilaria; Corvaja, Carla; Aliaga, Pamela Trillo; Del Signore, Ester; Spitaleri, Gianluca; Passaro, Antonio; de Marinis, Filippo
errShare
errSave
Plain language summary of the EVOKE-01 study of sacituzumab govitecan vs docetaxel in patients with non-small cell lung cancer
errFUTURE ONCOLOGY
IF2.6
err2025-05-15
err0
errOAAI
errLuis G Paz-Ares; Oscar Juan-Vidal; Giannis S Mountzios; Enriqueta Felip; Niels Reinmuth; Filippo de Marinis; Nicolas Girard; Vipul M Patel; Takayuki Takahama; Scott P Owen; Douglas M Reznick; Firas B Badin; Irfan Cicin; Sabeen Mekan; Riddhi Patel; Eric Zhang; Divyadeep Karumanchi; Marina Chiara Garassino
errShare
errSave
Immunotherapy in advanced non-small cell lung cancer: What to do for the 'Invisible' patients after IPSOS trial results?
errLUNG CANCER
IF4.4
err2025-04-01
err0
PREAI
errGridelli, Cesare; Attili, Ilaria; Bennati, Chiara; Bironzo, Paolo; Bria, Emilio; Cortinovis, Diego L.; Parra, Hector Soto; de Marinis, Filippo
errShare
errSave
A rationale for the poor response to alectinib in a patient with adenocarcinoma of the lung harbouring a STRN-ALK fusion by artificial intelligence and molecular modelling: a case report
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2024-12-01
err0
errOAAI
errBarberis, Massimo; Rappa, Alessandra; de Marinis, Filippo; Pelosi, Giuseppe; Rocco, Elena Guerini; Zhan, Yinxiu; Tiana, Guido
errShare
errSave
Patient-reported outcomes in patients with metastatic non-squamous non-small cell lung cancer from the randomized Phase II PERLA trial comparing first-line chemotherapy plus dostarlimab or pembrolizumab
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-11-01
err0
errOAAI
errReck, Martin; Granados, Ana Laura Ortega; de Marinis, Filippo; Meyers, Oren; Shen, Qin; Cho, Lillian; Stjepanovic, Neda; Boklage, Susan
errShare
errSave
Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development
errCANCER TREATMENT REVIEWS
IF10.5
err2024-11-01
err1
PREAI
errCorvaja, Carla; Passaro, Antonio; Attili, Ilaria; Aliaga, Pamela Trillo; Spitaleri, Gianluca; Del Signore, Ester; de Marinis, Filippo
errShare
errSave
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2024-10-24
err25
PREAI
errCho, Byoung C.; Lu, Shun; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Lee, Jong-Seok; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Yang, James C. -H.; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong I.; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan C.; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet A. N.; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Passaro, Antonio; Kim, Sang-We; Gadgeel, Shirish M.; Xie, John; Sun, Tao; Martinez, Melissa; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Millington, Dawn; Leconte, Isabelle; Iwasawa, Ryota; Lorenzini, Patricia; Baig, Mahadi; Shah, Sujay; Bauml, Joshua M.; Shreeve, S. Martin; Sethi, Seema; Knoblauch, Roland E.; Hayashi, Hidetoshi
errShare
errSave
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer
errFUTURE ONCOLOGY
IF2.6
err2024-10-03
err0
errOAAI
errSolomon, Benjamin J.; Liu, Geoffrey; Felip, Enriqueta; Mok, Tony S. K.; Soo, Ross A.; Mazieres, Julien; Shaw, Alice T.; de Marinis, Filippo; Goto, Yasushi; Wu, Yi-Long; Kim, Dong-Wan; Martini, Jean-Francois; Messina, Rossella; Paolini, Jolanda; Polli, Anna; Thomaidou, Despina; Toffalorio, Francesca; Bauer, Todd M.
errShare
errSave
ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK plus non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err4
PREAI
errSolomon, B. J.; Wu, Y-L.; Dziadziuszko, R.; Barlesi, F.; Nishio, M.; Ahn, J. S.; Horinouchi, H.; Hochmair, M. J.; de Marinis, F.; Migliorino, M. R.; Kurochkin, A.; Harputluoglu, H.; Planchard, D.; Korphaisarn, K.; Han, J-Y.; Lohmann, T.; Gavaldon, A. Cardona; Archer, V. R.; Nowicka, M.; Noe, J.
errShare
errSave
Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis
errJOURNAL OF CLINICAL MEDICINE
IF2.9
err2024-07-31
err1
errOAAI
errAttili, Ilaria; Asnaghi, Riccardo; Vacirca, Davide; Adorisio, Riccardo; Rappa, Alessandra; Ranghiero, Alberto; Lombardi, Mariano; Corvaja, Carla; Fuorivia, Valeria; Carnevale Schianca, Ambra; Trillo Aliaga, Pamela; Spitaleri, Gianluca; Del Signore, Ester; Guarize, Juliana; Spaggiari, Lorenzo; Guerini-Rocco, Elena; Fusco, Nicola; de Marinis, Filippo; Passaro, Antonio
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Pasi A. Jänne
H-index: 163 · Papers: 2.3K
G
Giuseppe Viale
H-index: 157 · Papers: 1.3K
M
Ming‐Sound Tsao
H-index: 151 · Papers: 1.6K
J
James Chih‐Hsin Yang
H-index: 141 · Papers: 1.2K
Y
Yi‐Long Wu
H-index: 135 · Papers: 2.2K
View more